Skip to main content
. 2022 Apr 19;27(6):432–e452. doi: 10.1093/oncolo/oyab075

Figure 1.

Figure 1.

Kaplan-Meier curves for (A) progression-free survival and (B) overall survival, stratified by cohort. The median progression-free survival was 2.33 (95% CI 1.81-Inf) months in cohort 1 and 5.85 (95% CI 2.99-8.61) months in cohort 2. Median overall survival was 4.5 (95% CI 2.33-Inf) months in cohort 1 and 10.9 (95% CI 6.97-16.4) months in cohort 2.